Evan Bloch

Research output

Research output per year 2006 2020 2021 2022 2023 2024

• 145 Article
• 32 Review article
• 6 Comment/debate
• 6 Editorial
• 8 More
  • 4 Chapter
  • 4 Letter

Research output per year

Research output per year

Search results

• 2024

  Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload

  Mercure-Corriveau, N., Crowe, E. P., Vozniak, S., Feng, X., Rai, H., Van Denakker, T., Zakieh, A., Grabowski, M. K., Lanzkron, S., Tobian, A. A. R. & Bloch, E. M., Jan 2024, In: Transfusion. 64, 1, p. 124-131 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Anemia 77%
  • Transfusion Reaction 60%
  • Erythrocytes 44%
  • Erythrocyte Transfusion 14%

• The potential association between extracorporeal photopheresis and thrombosis

  Jacobs, J. W., Adkins, B. D., Bibb, L. A., Woo, J. S., Allen, E. S., Stephens, L. D., Binns, T. C., Bloch, E. M. & Booth, G. S., Feb 2024, In: Bone marrow transplantation. 59, 2, p. 270-273 4 p.

  Research output: Contribution to journal › Letter › peer-review

• Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review

  Jacobs, J. W., Sharma, D., Stephens, L. D., Figueroa Villalba, CA., Rinder, H. M., Woo, J. S., Wheeler, AP., Gerberi, D., Goel, R., Tormey, C. A., Booth, G. S., Bloch, E. M. & Adkins, B. D., 2024, (Accepted/In press) In: British journal of haematology.

  Research output: Contribution to journal › Article › peer-review

  • Hemoglobin C Disease 100%
  • Hemoglobin C 85%
  • Thrombosis 40%
  • Systematic Reviews 38%
  • hemoglobin AA 28%
• 2023

  Absence of pathogenic viruses in COVID-19 convalescent plasma

  Kandathil, A. J., Benner, S. E., Bloch, E. M., Shrestha, R., Ajayi, O., Zhu, X., Caturegli, P. P., Shoham, S., Sullivan, D., Gebo, K., Quinn, T. C., Casadevall, A., Hanley, D., Pekosz, A., Redd, A. D., Balagopal, A. & Tobian, A. A. R., Jan 2023, In: Transfusion. 63, 1, p. 23-29 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Torque teno virus 100%
  • Viruses 44%
  • Anelloviridae 30%
  • Cytomegalovirus 24%
  • Human Herpesvirus 4 24%

• Advancing blood transfusion safety using molecular detection in the country of Georgia

  Alkhazashvili, M., Bloch, E. M., Shadaker, S., Kuchuloria, T., Getia, V., Turdziladze, A., Armstrong, P. A. & Gamkrelidze, A., Aug 2023, In: Transfusion clinique et biologique. 30, 3, p. 307-313 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Blood Safety 100%
  • Nucleic Acids 70%
  • Blood Transfusion 67%
  • Safety 60%
  • Nucleic Acid 60%

• Climate change and parasitic risk to the blood supply

  the International Society of Blood Transfusion Working Party Parasite Subgroup, Mar 2023, In: Transfusion. 63, 3, p. 638-645 8 p.

  Research output: Contribution to journal › Review article › peer-review

• Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV-2 in a US-like population

  Kostandova, N., Drabo, E. F., Yenokyan, K., Wesolowski, A., Truelove, S., Bloch, E. M., Tobian, A. A. R., Vassallo, R. R., Bravo, M. D., Casadevall, A., Lessler, J. & Lau, B., Jan 2023, In: Transfusion. 63, 1, p. 92-103 12 p.

  Research output: Contribution to journal › Article › peer-review

  • SARS Virus 100%
  • Mortality 34%
  • Infections 32%
  • Population 26%
  • Outpatients 21%

• Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data from the National Inpatient Sample

  Bloch, E. M., Goel, R., Zhu, X., Patel, E. U., Shoham, S., Sullivan, D. J., Gebo, K. A., Casadevall, A. & Tobian, A. A. R., Jul 15 2023, In: Clinical Infectious Diseases. 77, 2, p. 237-241 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Inpatients 63%
  • Geography 33%
  • Insurance 26%
  • Hospitalization 19%

• Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

  Zhu, X., Gebo, K. A., Abraham, A. G., Habtehyimer, F., Patel, E. U., Laeyendecker, O., Gniadek, T. J., Fernandez, R. E., Baker, O. R., Ram, M., Cachay, E. R., Currier, J. S., Fukuta, Y., Gerber, J. M., Heath, S. L., Meisenberg, B., Huaman, M. A., Levine, A. C., Shenoy, A., Anjan, S., & 28 othersBlair, J. E., Cruser, D., Forthal, D. N., Hammitt, L. L., Kassaye, S., Mosnaim, G. S., Patel, B., Paxton, J. H., Raval, J. S., Sutcliffe, C. G., Abinante, M., Broderick, P., Cluzet, V., Cordisco, M. E., Greenblatt, B., Petrini, J., Rausch, W., Shade, D., Lane, K., Gawad, A. L., Klein, S. L., Pekosz, A., Shoham, S., Casadevall, A., Bloch, E. M., Hanley, D., Sullivan, D. J. & Tobian, A. A. R., Sep 2023, In: The Lancet Microbe. 4, 9, p. e692-e703

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Chemokines 63%
  • Vaccination 54%
  • Cohort Studies 46%
  • Prospective Studies 43%

• Early antibody treatment, inflammation, and risk of post-COVID conditions

  CSSC-004 Consortium, Oct 2023, In: mBio. 14, 5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inflammation 100%
  • Antibodies 94%
  • SARS Virus 93%
  • Cytokines 52%
  • Interleukin-6 49%

• Eligibility Considerations for Female Whole Blood Donors: Hemoglobin Levels and Iron Status in a Nationally Representative Population

  Spencer, B. R., White, J. L., Patel, E. U., Goel, R., Bloch, E. M. & Tobian, A. AR., Jan 2023, In: Transfusion medicine reviews. 37, 1, p. 27-35 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ferritin 100%
  • Ferritins 84%
  • Blood Donors 82%
  • Hemoglobin 75%
  • Iron 67%

• Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients with Coronavirus Disease 2019

  Bloch, E. M., Focosi, D., Shoham, S., Senefeld, J., Tobian, A. A. R., Baden, L. R., Tiberghien, P., Sullivan, D. J., Cohn, C., Dioverti, V., Henderson, J. P., So-Osman, C., Juskewitch, J. E., Razonable, R. R., Franchini, M., Goel, R., Grossman, B. J., Casadevall, A., Joyner, M. J., Avery, R. K., & 2 othersPirofski, L. A. & Gebo, K. A., Jun 1 2023, In: Clinical Infectious Diseases. 76, 11, p. 2018-2024 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Immunocompromised Host 84%
  • Severe Acute Respiratory Syndrome 29%
  • Practice Guidelines 21%
  • Infectious Disease Medicine 19%

• How do we ensure a safe ABO recheck process?

  Stephens, L. D., Allen, E. S., Bloch, E. M., Crowe, E. P., Campbell-Lee, S. A., Booth, G. S. & Kopko, P., Oct 2023, In: Transfusion. 63, 10, p. 1789-1796 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transfusion Medicine 100%
  • Specimen Handling 32%

• Human babesiosis

  Smith, R. P., Bloch, E., Kumar, S. & Krause, P. J., Jan 1 2023, Molecular Medical Microbiology, Third Edition. Elsevier, p. 3031-3047 17 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Babesia 100%
  • Babesiosis 99%
  • Babesia microti 28%
  • Atovaquone 27%
  • Ixodidae 27%

• Human Borrelia miyamotoi Infection in North America

  Burde, J., Bloch, E. M., Kelly, J. R. & Krause, P. J., Apr 2023, In: Pathogens. 12, 4, 553.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Borrelia Infections 100%
  • Ticks 70%
  • North America 64%
  • Ixodes 27%
  • Borrelia 27%

• Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19

  OP11 Clinical Staff, Feb 23 2023, In: Nature. 614, 7949, p. 752-761 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Influenza 100%
  • Vaccination 86%
  • Interleukin-15 68%
  • Monocytes 67%
  • Virus Diseases 39%

• Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases

  Bloch, E. M., Busch, M. P., Corash, L. M., Dodd, R., Hailu, B., Kleinman, S., O'Brien, S., Petersen, L., Stramer, S. L. & Katz, L., Oct 2023, In: Transfusion medicine reviews. 37, 4, 150769.

  Research output: Contribution to journal › Article › peer-review

  • Emerging Communicable Diseases 100%
  • Blood Safety 75%
  • Blood Donors 72%
  • Donor Selection 69%
  • Epidemiology 56%

• Lower anti-spike levels in B-cell-depleted patients after convalescent plasma transfusion suggest the need for repeated doses

  Focosi, D., Senefeld, J. W., Joyner, M. J., Sullivan, D., Casadevall, A., Bloch, E. M. & Franchini, M., Jan 2023, In: British journal of haematology. 200, 2, p. e22-e24

  Research output: Contribution to journal › Letter › peer-review

• Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19

  Van Denakker, T. A., Al-Riyami, A. Z., Feghali, R., Gammon, R., So-Osman, C., Crowe, E. P., Goel, R., Rai, H., Tobian, A. A. R. & Bloch, E. M., 2023, In: Expert review of hematology. 16, 7, p. 501-514 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Natural Disasters 100%
  • Pandemics 76%
  • Emergencies 55%
  • Income 14%
  • Tissue Donors 14%

• Molecular Screening of Blood Donors for Babesia in Tyrol, Austria

  Bloch, E. M., Siller, A., Tonnetti, L., Drews, S. J., Spencer, B. R., Hedges, D., Mergenthal, T., Weber-Schehl, M., Astl, M., Patel, E. U., Gaber, M. & Schennach, H., Aug 2 2023, In: Transfusion Medicine and Hemotherapy. 50, 4, p. 330-333 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Babesia 100%
  • Austria 83%
  • Blood Donors 70%
  • Babesiosis 37%
  • Ticks 30%

• Optimizing Blood Transfusion in Patients with Acute Myocardial Infarction.

  Bloch, E. M. & Tobian, A. A. R., Dec 28 2023, In: New England Journal of Medicine. 389, 26, p. 2483-2485 3 p.

  Research output: Contribution to journal › Editorial › peer-review

• Overcoming challenges in managing a high-risk pregnancy with placenta previa and newly diagnosed Bombay phenotype

  Van Denakker, T. A., Haddaway, K., Cunningham, A., Leonard, K., Darwin, K., Meeks, M., Lawson, S. M., Vaught, A., Moliterno, A., Frank, S. M., Tobian, A., Crowe, E., Bloch, E. & Rai, H., Dec 2023, In: Transfusion and Apheresis Science. 62, 6, 103832.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Placenta Previa 100%
  • High-Risk Pregnancy 94%
  • Phenotype 44%
  • Strategic Planning 42%
  • Directed Tissue Donation 27%

• Pediatric firearm injury related emergency department visits and hospitalizations: a population-based study in the United States

  Goel, R., Zhu, X., Makhani, S., Josephson, C. D., White, J. L., Karam, O., Nellis, M. E., Gehrie, E. A., Sherpa, M., Crowe, E. P., Bloch, E. M. & Tobian, A. A. R., Jun 2023, In: Lancet Regional Health - Americas. 22, 100503.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Firearms 100%
  • hospitalization 97%
  • Hospital Emergency Service 70%
  • Hospitalization 64%
  • Pediatrics 56%

• Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium

  Custer, B., Bloch, E. M., Bryant, B. J., D'Alessandro, A., Delaney, M., Goel, R., Hod, E. A., Josephson, C. D., Katz, L. M., Miller, Y. M., Sayers, M. H., Seheult, J. N., Triulzi, D. J., Berger, J., Zou, S., Hailu, B., Glynn, S. A. & Roubinian, N. H., 2023, (Accepted/In press) In: Transfusion.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transfusion Medicine 100%
  • National Heart, Lung, and Blood Institute (U.S.) 97%
  • Health 34%
  • Tissue Donors 27%
  • Government Employees 17%

• P-TS-42 | Implementing Low-Titer Group O Whole Blood: A Level 1 Trauma Center Experience

  Van Denakker, T., Charity, K., Marshall, C., Neally, M., Rai, H., Bloch, E., Tobian, A. & Crowe, E., Oct 2023, In: Transfusion. 63, S5, p. 283A

  Research output: Contribution to journal › Article › peer-review

• Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults

  Huso, T., Buban, K., Van Denakker, T. A., Haddaway, K., Smetana, H., Marshall, C., Rai, H., Ness, P. M., Bloch, E. M., Tobian, A. A. R. & Crowe, E. P., 2023, (Accepted/In press) In: Transfusion.

  Research output: Contribution to journal › Article › peer-review

  • Erythrocyte Transfusion 100%
  • Erythrocytes 55%
  • Transfusion Reaction 40%
  • Hypersensitivity 24%
  • Pruritus 20%

• SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019–2022

  Bloch, E. M., Kyeyune, D., White, J. L., Ddungu, H., Ashokkumar, S., Habtehyimer, F., Baker, O., Kasirye, R., Patel, E. U., Grabowski, M. K., Musisi, E., Moses, K., Hume, H. A., Lubega, I., Shrestha, R., Motevalli, M., Fernandez, R. E., Reynolds, S. J., Redd, A. D., Wambongo Musana, H., & 17 othersDhabangi, A., Ouma, J., Eroju, P., de Lange, T., Fowler, M. G., Musoke, P., Stramer, S. L., Whitby, D., Zimmerman, P. A., McCullough, J., Sachithanandham, J., Pekosz, A., Goodrich, R., Quinn, T. C., Ness, P. M., Laeyendecker, O. & Tobian, A. A. R., Jul 2023, In: Transfusion. 63, 7, p. 1354-1365 12 p.

  Research output: Contribution to journal › Article › peer-review

  • SARS Virus 100%
  • Uganda 80%
  • Seroepidemiologic Studies 75%
  • Blood Donors 69%
  • Tissue Donors 44%

• SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

  Hederman, A. P., Natarajan, H., Heyndrickx, L., Ariën, K. K., Wiener, J. A., Wright, P. F., Bloch, E. M., Tobian, A. A. R., Redd, A. D., Blankson, J. N., Rottenstreich, A., Zarbiv, G., Wolf, D., Goetghebuer, T., Marchant, A. & Ackerman, M. E., Dec 2023, In: Nature communications. 14, 1, 5171.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • effectors 100%
  • SARS Virus 96%
  • antibodies 77%
  • Effector 71%
  • Vulnerable Populations 68%

• Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization

  McConnell, S. A., Sachithanandham, J., Mudrak, N. J., Zhu, X., Farhang, P. A., Cordero, R. J. B., Wear, M. P., Shapiro, J. R., Park, H. S., Klein, S. L., Tobian, A. A. R., Bloch, E. M., Sullivan, D. J., Pekosz, A. & Casadevall, A., Jul 20 2023, In: Cell Chemical Biology. 30, 7, p. 726-738.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Neutralization 68%
  • Protein Hydrolysis 48%
  • Plasma 41%
  • Antibodies 37%

• Survey of blood collection and transfusion practices among institutions in Africa

  Jacobs, J. W., Stephens, L. D., Milner, D. A., Bloch, E. M., Goel, R., Tobian, A. A. R., Shibemba, A. L. & Eichbaum, Q., Oct 2023, In: Transfusion. 63, 10, p. 1849-1858 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Blood Transfusion 100%
  • Transfusion Medicine 55%
  • Blood Donors 40%
  • Communicable Diseases 34%
  • Blood Banks 33%

• Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial

  Baksh, S. N., Heath, S. L., Fukuta, Y., Shade, D., Meisenberg, B., Bloch, E. M., Tobian, A. A. R., Spivak, E. S., Patel, B., Gerber, J., Raval, J. S., Forthal, D., Paxton, J., Mosnaim, G., Anjan, S., Blair, J., Cachay, E., Currier, J., Das, P., Huaman, M., & 6 othersSutcliffe, C., Yarava, A., Casadevall, A., Sullivan, D., Hanley, D. & Gebo, K. A., Jun 1 2023, In: Journal of Infectious Diseases. 227, 11, p. 1266-1273 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Outpatients 59%
  • Hospitalization 14%
  • Therapeutics 13%
  • Cough 9%

• Therapeutic Plasma Exchange: Core Curriculum 2023

  Cervantes, C. E., Bloch, E. M. & Sperati, C. J., Apr 2023, In: American Journal of Kidney Diseases. 81, 4, p. 475-492 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Plasma Exchange 100%
  • Curriculum 80%
  • Nephrologists 51%
  • Kidney Diseases 21%
  • Renal Dialysis 17%

• Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature

  Mercure-Corriveau, N., Roy, S., Hu, C., Crowe, E. P., Zhu, X., Obando, D., Patel, E. U., Tobian, A. A. R., Wang, Y., Bloch, E. M. & Newsome, S. D., Jan 1 2023, In: Therapeutic Advances in Neurological Disorders. 16

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Plasma Exchange 77%
  • Therapeutics 10%
  • Progressive Encephalomyelitis with Rigidity 4%
  • Cerebellar Ataxia 2%

• Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

  Shoham, S., Bloch, E. M., Casadevall, A., Hanley, D., Lau, B., Gebo, K., Cachay, E., Kassaye, S. G., Paxton, J. H., Gerber, J., Levine, A. C., Naeim, A., Currier, J., Patel, B., Allen, E. S., Anjan, S., Appel, L., Baksh, S., Blair, P. W., Bowen, A., & 36 othersBroderick, P., Caputo, C. A., Cluzet, V., Cordisco, M. E., Cruser, D., Ehrhardt, S., Forthal, D., Fukuta, Y., Gawad, A. L., Gniadek, T., Hammel, J., Huaman, M. A., Jabs, D. A., Jedlicka, A., Karlen, N., Klein, S., Laeyendecker, O., Lane, K., McBee, N., Meisenberg, B., Merlo, C., Mosnaim, G., Park, H. S., Pekosz, A., Petrini, J., Rausch, W., Shade, D. M., Shapiro, J. R., Robinson Singleton, J., Sutcliffe, C., Thomas, D. L., Yarava, A., Zand, M., Zenilman, J. M., Tobian, A. A. R. & Sullivan, D. J., Feb 1 2023, In: Clinical Infectious Diseases. 76, 3, p. E477-E486

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Post-Exposure Prophylaxis 100%
  • Severe Acute Respiratory Syndrome 88%
  • Coronavirus 60%
  • Randomized Controlled Trials 46%
  • Infections 13%

• Transfusion medicine research in Africa: Insights from investigators in the field

  for the AABB Global Transfusion Forum contributed equally, Apr 2023, In: Vox sanguinis. 118, 4, p. 281-287 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transfusion Medicine 100%
  • Research Personnel 49%
  • Health Priorities 11%
  • Efficiency 9%
  • Publications 7%

• Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials

  Huaman, M. A., Raval, J. S., Paxton, J. H., Mosnaim, G. S., Patel, B., Anjan, S., Meisenberg, B. R., Levine, A. C., Marshall, C. E., Yarava, A., Shenoy, A. G., Heath, S. L., Currier, J. S., Fukuta, Y., Blair, J. E., Spivak, E. S., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., & 38 othersHammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Kassaye, S. G., Ram, M., Wang, Y., Das, P., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Ford, D. E., Laeyendecker, O., Pekosz, A., Klein, S. L., Ehrhardt, S., Lau, B., Baksh, S. N., Shade, D. M., Casadevall, A., Hanley, D. F., Ou, J., Gniadek, T. J., Ziman, A., Shoham, S., Gebo, K. A., Bloch, E. M., Tobian, A. A. R., Sullivan, D. J. & Gerber, J. M., Sep 2023, In: Transfusion. 63, 9, p. 1639-1648 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transfusion Reaction 100%
  • Outpatients 56%
  • Clinical Trials 49%
  • Urticaria 17%
  • Hospitalization 16%

• Transfusion-transmitted Babesia spp. a changing landscape of epidemiology, regulation, and risk mitigation

  Drews, S. J., Kjemtrup, A. M., Krause, P. J., Lambert, G., Leiby, D. A., Lewin, A., O'Brien, S. F., Renaud, C., Tonnetti, L. & Bloch, E. M., Oct 2023, In: Journal of clinical microbiology. 61, 10

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Babesia 100%
  • Epidemiology 54%
  • Climate Change 10%
  • Ticks 8%
  • North America 7%

• Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange

  Costa, V., Mercure-Corriveau, N., Gourneau, J., Tobian, A. A. R., Jones, J. M., Lauriello, A., Lanzkron, S., Crowe, E. P. & Bloch, E. M., Mar 2023, In: Transfusion. 63, 3, p. 652-655 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Babesia 100%
  • Babesiosis 99%
  • Sickle Cell Anemia 76%
  • Arvicolinae 39%
  • Fever 31%
• 2022

  Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

  Park, H. S., Shapiro, J. R., Sitaras, I., Woldemeskel, B. A., Garliss, C. C., Dziedzic, A., Sachithanandham, J., Jedlicka, A. E., Caputo, C. A., Rousseau, K. E., Thakar, M., Suwanmanee, S., Hauk, P., Aliyu, L., Majewska, N. I., Koley, S., Patel, B., Broderick, P., Mosnaim, G., Heath, S. L., & 18 othersSpivak, E. S., Shenoy, A., Bloch, E. M., Gniadek, T. J., Shoham, S., Casadevall, A., Hanley, D., Cox, A. L., Laeyendecker, O., Betenbaugh, M. J., Cramer, S. M., Mostafa, H. H., Pekosz, A., Blankson, J. N., Klein, S. L., Tobian, A. A. R., Sullivan, D. & Gebo, K. A., Mar 8 2022, In: JCI Insight. 7, 5, e155944.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Adaptive Immunity 69%
  • Neutralizing Antibodies 50%
  • Viruses 45%
  • Vaccination 40%

• Algorithm-based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease

  Buban, K. R., Lawrence, C. E., Zhu, X. J., Tobian, A. A. R., Gehrie, E. A., Vozniak, S., Shrestha, R., Lokhandwala, P. M. & Bloch, E. M., Oct 2022, In: Journal of Clinical Apheresis. 37, 5, p. 468-475 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Erythrocytes 71%
  • Procedures and Techniques Utilization 15%
  • Sickle Hemoglobin 14%
  • Hematocrit 10%

• Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2

  Natarajan, H., Xu, S., Crowley, A. R., Butler, S. E., Weiner, J. A., Bloch, E. M., Littlefield, K., Benner, S. E., Shrestha, R., Ajayi, O., Wieland-Alter, W., Sullivan, D., Shoham, S., Quinn, T. C., Casadevall, A., Pekosz, A., Redd, A. D., Tobian, A. A. R., Connor, R. I., Wright, P. F., & 1 othersAckerman, M. E., Dec 2022, In: BMC Immunology. 23, 1, 7.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Antibodies 37%
  • Antibody Formation 17%
  • Machine Learning 10%
  • Phagocytosis 9%

• Associated comorbidities, healthcare utilization & mortality in hospitalized patients with haemophilia in the United States: Contemporary nationally representative estimates

  Day, J. R., Takemoto, C., Sharathkumar, A., Makhani, S., Gupta, A., Bitner, S., Josephson, C. D., Bloch, E. M., Tobian, A. A. R., Krishnamurti, L. & Goel, R., Jul 2022, In: Haemophilia. 28, 4, p. 532-541 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemophilia A 100%
  • Comorbidity 69%
  • Delivery of Health Care 53%
  • Mortality 44%
  • Hospitalization 32%

• Bacterial contamination of blood components

  Bloch, E. M., Benjamin, R. J. & Ramirez-Arcos, S., Jul 10 2022, Rossi's Principles of Transfusion Medicine. wiley, p. 533-542 10 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Blood Transfusion 100%
  • Sepsis 85%
  • Blood Platelets 55%
  • Transfusion Reaction 46%
  • Donor Selection 46%

• Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

  Crowley, A. R., Natarajan, H., Hederman, A. P., Bobak, C. A., Weiner, J. A., Wieland-Alter, W., Lee, J., Bloch, E. M., Tobian, A. A. R., Redd, A. D., Blankson, J. N., Wolf, D., Goetghebuer, T., Marchant, A., Connor, R. I., Wright, P. F. & Ackerman, M. E., Mar 2022, In: eLife. 11, e75228.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Coronavirus 85%
  • Neutralization 68%
  • Vaccination 54%
  • Antibodies 37%

• Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

  Estcourt, L. J., Cohn, C. S., Pagano, M. B., Iannizzi, C., Kreuzberger, N., Skoetz, N., Allen, E. S., Bloch, E. M., Beaudoin, G., Casadevall, A., Devine, D. V., Foroutan, F., Gniadek, T. J., Goel, R., Gorlin, J., Grossman, B. J., Joyner, M. J., Metcalf, R. A., Raval, J. S., Rice, T. W., & 4 othersShaz, B. H., Vassallo, R. R., Winters, J. L. & Tobian, A. A. R., Sep 1 2022, In: Annals of internal medicine. 175, 9, p. 1310-1321 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biological Therapy 100%
  • Practice Guidelines 79%
  • SARS Virus 27%
  • Standard of Care 27%
  • Inpatients 22%

• Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States

  Bloch, E. M., Zhu, X., Krause, P. J., Patel, E. U., Grabowski, M. K., Goel, R., Auwaerter, P. G. & Tobian, A. A. R., Nov 1 2022, In: Open Forum Infectious Diseases. 9, 11, ofac597.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Babesiosis 100%
  • Lyme Disease 85%
  • Epidemiology 55%
  • Hospitalization 51%
  • Health 34%

• Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

  Li, M., Beck, E. J., Laeyendecker, O., Eby, Y., Tobian, A. A. R., Caturegli, P., Wouters, C., Chiklis, G. R., Block, W., McKie, R. O., Joyner, M. J., Wiltshire, T. D., Dietz, A. B., Gniadek, T. J., Shapiro, A. J., Yarava, A., Lane, K., Hanley, D. F., Bloch, E. M., Shoham, S., & 14 othersCachay, E. R., Meisenberg, B. R., Huaman, M. A., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Paxton, J. H., Anjan, S., Gerber, J. M., Gebo, K. A., Casadevall, A., Pekosz, A. & Sullivan, D. J., Jun 28 2022, In: Blood Advances. 6, 12, p. 3678-3683 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Viruses 51%
  • Antibodies 42%
  • Tissue Donors 30%

• COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries

  the AABB Global Transfusion Forum, Feb 2022, In: Transfusion. 62, 2, p. 336-345 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus 100%
  • Blood Transfusion 74%
  • Income 65%
  • Pandemics 30%
  • Social Media 8%

• Deferral of men who have sex with men from blood donation: Policy and change

  Bloch, E. M., Aug 2022, In: Transfusion clinique et biologique. 29, 3, p. 195-197 3 p.

  Research output: Contribution to journal › Editorial › peer-review

• Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals

  Saraf, S., Zhu, X., Shrestha, R., Bonny, T. S., Baker, O. R., Beck, E. J., Fernandez, R. E., Eby, Y., Akinde, O., Ruff, J. E., Caturegli, P., Redd, A. D., Bloch, E. M., Quinn, T. C., Tobian, A. A. R. & Laeyendecker, O., Jun 2022, In: PloS one. 17, 6 June, e0264298.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Antibody Formation 60%
  • Odds Ratio 43%
  • Antibodies 31%
  • Pharyngitis 26%